MAYA – CORPORATE ACTIONS

” ..Omnix Medical, a Biotech company located in Jerusalem and dedicated to the development of novel antimicrobial drugs, is very happy to announce that: OMN6, the company’s leading peptide, has been designated Qualified Infectious Disease Product (QIDP) by the US Food and Drug Administration (FDA)…” MAYA – CORPORATE ACTIONS Tel-Aviv Stock Exchange

The release as fetched from its publisher. omnixmedical.com ↗